Charles River Laboratories International Inc Receivables Turnover Ratio (CRL), from the second quarter 2026 to the second quarter 2025 current and historic results, rankings and more - CSIMarket
CSIMarket
 


Charles River Laboratories International inc   (NYSE: CRL)
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

Charles River Laboratories International Inc Accounts Receivables Turnover Ratio from the second quarter 2026 to the second quarter 2025

Quarterly Results, Trends, Rankings, Statistics


Charles River Laboratories International Inc 's ability to collect accounts receivable sequentially worsen to 5.44, indicating more challenging environment then in the first quarter 2026, but still, it is a far cry from any concerns. Charles River Laboratories International Inc 's Accounts Receivable average collection period in the Jun 27 2026 quarter, has increased to 67 days, from 66 days, in the Mar 28 2026 quarter.

If we take a look into Healthcare sector 269 other companies have achieved higher receivables turnover ratio. While receivables turnover ratio total ranking has improved thus far to 1913, from overall ranking in the first quarter 2026 at 2375.

What is Receivable Turnover Ratio?
What is Charles River Laboratories International Inc Selling?


What is Receivable Turnover Ratio?





CRL Receivables Turnover Ratio (Jun 27 2026)
II. Quarter
(Mar 28 2026)
I. Quarter
(Dec 27 2025)
IV. Quarter
(Sep 27 2025)
III. Quarter
(Jun 28 2025)
II. Quarter
Y / Y Receivable Change 3.58 % -7.45 % -1.67 % -2.62 % 0.7 %
Y / Y Revenue Change -2.72 % 1.18 % -0.83 % -0.49 % 0.59 %
Receivable Turnover Ratio (TTM) 5.44 5.53 5.41 5.4 5.37
CRL's Total Ranking # 1913 # 2375 # 2231 # 1204 # 1771
Accounts Receivable average collection period days 67 66 67 68 68
Seq. Receivable Change 13.53 % -1.21 % -3.49 % -4.31 % 1.45 %
Seq. Revenue Change 0.83 % 0.16 % -1.06 % -2.64 % 4.87 %


Receivable Turnover Company Ranking
Within: No.
Medical Laboratories Industry # 20
Healthcare Sector # 270
Overall Market # 1913

Receivable Turnover Ratio Statistics
High Average Low
0.72 0.58 -0.35
(Jun 28 2014)   (Sep 28 2013)






Financial Statements
Charles River Laboratories International Inc 's Accounts Receivable $ 795 Millions Visit CRL's Balance sheet
Charles River Laboratories International Inc 's Sales TTM $ 3,999 Millions Visit CRL's Income Statement
Sources of CRL's Revenues Visit CRL's Sales by Geography

Other Accounts Receivable Turnover Ratios
Medical Laboratories Industry Accounts Receivable Turnover Trends and Statistics
Healthcare Sector Accounts Receivable Turnover Statistics
Accounts Receivables Turnover Trends for overall market
CRL's Receivable Turnover Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Accounts Receivables Turnover
Lowest Ranking Accounts Receivables Turnover

You may also want to know
CRL's Growth Rates CRL's Roa CRL's Inventory Turnover Ratio CRL's Dividend Comparisons
CRL's Profitability Ratios CRL's Roi CRL's Asset Turnover Ratio CRL's Dividend Growth
CRL's Valuation Ratios CRL's Roe CRL's Financial Strength Ratios CRL's Dividend Payout Ratio



Companies with similar Receivables Turnover Ratio for the quarter ending Jun 27 2026, within Healthcare Sector Receivable Turnover Ratio Revenues for 12 Months ending Jun 27 2026 Receivable at quarter ending Jun 27 2026
Ataibeckley Inc   13.83 $ 4.473  Millions$ 0.324  Millions
Amneal Pharmaceuticals Inc   13.83 $ 3,117.474  Millions$ 225.492  Millions
Arvinas Inc   13.49 $ 316.700  Millions$ 23.475  Millions
Rosecliff Acquisition Corp I  13.43 $ 16.467  Millions$ 1.226  Millions
Corcept Therapeutics Inc  13.30 $ 830.813  Millions$ 62.477  Millions
Precipio inc   13.25 $ 27.198  Millions$ 2.052  Millions
Skinhealth Systems Inc   13.04 $ 289.224  Millions$ 22.179  Millions
Chemed Corporation  12.94 $ 2,595.001  Millions$ 200.565  Millions
Qhslab Inc   12.77 $ 3.017  Millions$ 0.236  Millions
Petvivo Holdings Inc   12.34 $ 1.182  Millions$ 0.096  Millions
Alpha Pro Tech Ltd   12.25 $ 62.204  Millions$ 5.077  Millions
Vivos Therapeutics Inc   12.21 $ 21.135  Millions$ 1.731  Millions
Milestone Scientific Inc   11.82 $ 8.855  Millions$ 0.749  Millions
Marpai Inc  11.71 $ 16.635  Millions$ 1.420  Millions
Catheter Precision Inc   11.62 $ 1.915  Millions$ 0.165  Millions
Nrc Health  11.35 $ 139.996  Millions$ 12.337  Millions
Picard Medical Inc   11.34 $ 5.983  Millions$ 0.528  Millions
Veracyte Inc   11.07 $ 544.735  Millions$ 49.194  Millions
International Stem Cell Corporation  10.91 $ 9.514  Millions$ 0.872  Millions
Premier Air Charter Holdings Inc   10.66 $ 31.562  Millions$ 2.961  Millions
C4 Therapeutics Inc   10.65 $ 35.039  Millions$ 3.290  Millions
Lifeloc Technologies Inc   10.48 $ 9.269  Millions$ 0.884  Millions
Immucell Corporation  10.29 $ 29.777  Millions$ 2.893  Millions
Addus Homecare Corp  10.23 $ 1,475.610  Millions$ 144.195  Millions
Dariohealth Corp   10.23 $ 21.196  Millions$ 2.072  Millions
Radnet Inc   10.11 $ 2,268.932  Millions$ 224.447  Millions
Utah Medical Products Inc  9.88 $ 35.679  Millions$ 3.612  Millions
Lensar Inc   9.75 $ 60.264  Millions$ 6.184  Millions
Biolife Solutions Inc   9.67 $ 102.718  Millions$ 10.626  Millions
Encompass Health Corporation  9.57 $ 6,206.100  Millions$ 648.325  Millions

Date modified: 2026-09-01T19:51:46+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.